Who invested in Alethia BioTherapeutics?
Alethia BioTherapeutics's investors include BDC Capital, GeneChem, GO Capital Fund and Epicentre Technologies.

Canada · Series B startup
Funding summaryUpdated 26 Oct 2026
$14Mraised across 2 rounds since 2010, from 2 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
Reported by fis.dowjones.com
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Alethia BioTherapeutics's investors include BDC Capital, GeneChem, GO Capital Fund and Epicentre Technologies.
Alethia BioTherapeutics has raised $14M across 2 rounds since 2010.
Alethia BioTherapeutics's most recent round was a Series B of $4.7M in Nov 2012.
Alethia BioTherapeutics's largest round on record is $9.2M (Series A), in Sept 2010.
Alethia BioTherapeutics's first round on record, in Sept 2010, was backed by BDC Capital, GeneChem and GO Capital Fund and 1 others.
Alethia BioTherapeutics's latest named round is a Series B, in Nov 2012.
Alethia BioTherapeutics is based in Canada.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.